

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 4.42082970 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 4.32828530 |
| 3 | DNA unwinding involved in DNA replication (GO:0006268) | 4.26548097 |
| 4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.17269790 |
| 5 | protein localization to kinetochore (GO:0034501) | 4.05045461 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.03939806 |
| 7 | nuclear pore organization (GO:0006999) | 4.03759756 |
| 8 | nuclear pore complex assembly (GO:0051292) | 3.96500219 |
| 9 | mitotic nuclear envelope disassembly (GO:0007077) | 3.95742585 |
| 10 | barbed-end actin filament capping (GO:0051016) | 3.87676659 |
| 11 | glycolipid catabolic process (GO:0019377) | 3.86465888 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.84415190 |
| 13 | protein localization to endosome (GO:0036010) | 3.81904382 |
| 14 | pinocytosis (GO:0006907) | 3.79312291 |
| 15 | regulation of translational fidelity (GO:0006450) | 3.78701301 |
| 16 | heterochromatin organization (GO:0070828) | 3.77699157 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 3.75389945 |
| 18 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.71922099 |
| 19 | nuclear envelope disassembly (GO:0051081) | 3.66326787 |
| 20 | membrane disassembly (GO:0030397) | 3.66326787 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 3.62746635 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.61333322 |
| 23 | regulation of early endosome to late endosome transport (GO:2000641) | 3.50761543 |
| 24 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.45214426 |
| 25 | pre-miRNA processing (GO:0031054) | 3.43468087 |
| 26 | mannose metabolic process (GO:0006013) | 3.42444432 |
| 27 | IMP biosynthetic process (GO:0006188) | 3.41120611 |
| 28 | oligosaccharide catabolic process (GO:0009313) | 3.40959333 |
| 29 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.36381489 |
| 30 | protein localization to chromosome, centromeric region (GO:0071459) | 3.35385420 |
| 31 | DNA replication initiation (GO:0006270) | 3.35231530 |
| 32 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.30978996 |
| 33 | amino sugar catabolic process (GO:0046348) | 3.30642458 |
| 34 | response to thyroid hormone (GO:0097066) | 3.29791323 |
| 35 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.27164420 |
| 36 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.25721079 |
| 37 | ceramide catabolic process (GO:0046514) | 3.23951038 |
| 38 | DNA strand elongation (GO:0022616) | 3.23553635 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.22836898 |
| 40 | mitotic metaphase plate congression (GO:0007080) | 3.18966495 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 3.18595440 |
| 42 | IMP metabolic process (GO:0046040) | 3.14701304 |
| 43 | pore complex assembly (GO:0046931) | 3.13506956 |
| 44 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.08736021 |
| 45 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.08099952 |
| 46 | DNA duplex unwinding (GO:0032508) | 3.05157464 |
| 47 | nuclear envelope organization (GO:0006998) | 3.04706314 |
| 48 | DNA geometric change (GO:0032392) | 3.04522880 |
| 49 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.03860618 |
| 50 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.03049533 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 3.02851469 |
| 52 | regulation of gene silencing by RNA (GO:0060966) | 3.02779968 |
| 53 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.02779968 |
| 54 | regulation of gene silencing by miRNA (GO:0060964) | 3.02779968 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.02118773 |
| 56 | mitotic sister chromatid segregation (GO:0000070) | 3.01816416 |
| 57 | myeloid dendritic cell differentiation (GO:0043011) | 3.00126092 |
| 58 | positive regulation of chromosome segregation (GO:0051984) | 2.99953827 |
| 59 | membrane lipid catabolic process (GO:0046466) | 2.96377946 |
| 60 | nucleobase biosynthetic process (GO:0046112) | 2.96368871 |
| 61 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.95536718 |
| 62 | modulation by symbiont of host cellular process (GO:0044068) | 2.94682564 |
| 63 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.93880277 |
| 64 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.93880277 |
| 65 | sphingolipid catabolic process (GO:0030149) | 2.93052268 |
| 66 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.92411812 |
| 67 | regulation of podosome assembly (GO:0071801) | 2.90227367 |
| 68 | regulation of translational termination (GO:0006449) | 2.89954612 |
| 69 | apoptotic cell clearance (GO:0043277) | 2.88035541 |
| 70 | T-helper 1 type immune response (GO:0042088) | 2.87981754 |
| 71 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.87183156 |
| 72 | regulation of cholesterol storage (GO:0010885) | 2.86959648 |
| 73 | negative regulation of histone methylation (GO:0031061) | 2.86779795 |
| 74 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.83755483 |
| 75 | sister chromatid segregation (GO:0000819) | 2.82800200 |
| 76 | regulation of mitotic spindle organization (GO:0060236) | 2.82021794 |
| 77 | Golgi transport vesicle coating (GO:0048200) | 2.81699063 |
| 78 | COPI coating of Golgi vesicle (GO:0048205) | 2.81699063 |
| 79 | regulation of spindle organization (GO:0090224) | 2.80395358 |
| 80 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.79328482 |
| 81 | stress fiber assembly (GO:0043149) | 2.78886619 |
| 82 | mitotic chromosome condensation (GO:0007076) | 2.78283036 |
| 83 | chromatin assembly (GO:0031497) | 2.78040088 |
| 84 | regulation of leukocyte degranulation (GO:0043300) | 2.77345037 |
| 85 | folic acid metabolic process (GO:0046655) | 2.76936868 |
| 86 | mRNA stabilization (GO:0048255) | 2.76217384 |
| 87 | RNA stabilization (GO:0043489) | 2.76217384 |
| 88 | DNA replication checkpoint (GO:0000076) | 2.76056143 |
| 89 | adhesion of symbiont to host (GO:0044406) | 2.76053679 |
| 90 | germinal center formation (GO:0002467) | 2.75775294 |
| 91 | adhesion of symbiont to host cell (GO:0044650) | 2.74179294 |
| 92 | virion attachment to host cell (GO:0019062) | 2.74179294 |
| 93 | regulation of superoxide anion generation (GO:0032928) | 2.73882634 |
| 94 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.73189762 |
| 95 | metaphase plate congression (GO:0051310) | 2.70248169 |
| 96 | immunoglobulin mediated immune response (GO:0016064) | 2.70031156 |
| 97 | T cell apoptotic process (GO:0070231) | 2.69318165 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.68188789 |
| 99 | regulation of sister chromatid cohesion (GO:0007063) | 2.67828751 |
| 100 | NLS-bearing protein import into nucleus (GO:0006607) | 2.66848581 |
| 101 | N-acetylneuraminate metabolic process (GO:0006054) | 2.66785826 |
| 102 | telomere maintenance via recombination (GO:0000722) | 2.66606634 |
| 103 | regulation of vitamin metabolic process (GO:0030656) | 2.64993165 |
| 104 | tetrahydrofolate metabolic process (GO:0046653) | 2.64805488 |
| 105 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.63083630 |
| 106 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.62433921 |
| 107 | pentose-phosphate shunt (GO:0006098) | 2.62163946 |
| 108 | regulation of monocyte differentiation (GO:0045655) | 2.60661246 |
| 109 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60566336 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.59650686 |
| 111 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.59650686 |
| 112 | decidualization (GO:0046697) | 2.59516373 |
| 113 | maturation of SSU-rRNA (GO:0030490) | 2.59371996 |
| 114 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.59339778 |
| 115 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.58212073 |
| 116 | regulation of mast cell degranulation (GO:0043304) | 2.56365362 |
| 117 | myeloid dendritic cell activation (GO:0001773) | 2.56180009 |
| 118 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.55690421 |
| 119 | regulation of chemokine biosynthetic process (GO:0045073) | 2.55660343 |
| 120 | maternal placenta development (GO:0001893) | 2.55547092 |
| 121 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.55333072 |
| 122 | activation of MAPKKK activity (GO:0000185) | 2.54922178 |
| 123 | hyaluronan catabolic process (GO:0030214) | 2.54520232 |
| 124 | mitotic recombination (GO:0006312) | 2.53858659 |
| 125 | dosage compensation (GO:0007549) | 2.53797413 |
| 126 | B cell mediated immunity (GO:0019724) | 2.53781552 |
| 127 | regulation of macrophage chemotaxis (GO:0010758) | 2.53736659 |
| 128 | regulation of histone H3-K9 methylation (GO:0051570) | 2.53592598 |
| 129 | apoptotic process involved in morphogenesis (GO:0060561) | 2.53076680 |
| 130 | response to UV-C (GO:0010225) | 2.52503778 |
| 131 | regulation of RNA export from nucleus (GO:0046831) | 2.52033067 |
| 132 | establishment of chromosome localization (GO:0051303) | 2.51941217 |
| 133 | positive regulation of type 2 immune response (GO:0002830) | 2.51520429 |
| 134 | ribosome biogenesis (GO:0042254) | 2.50755550 |
| 135 | mitotic G1/S transition checkpoint (GO:0044819) | 2.50631846 |
| 136 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.48872808 |
| 137 | dendritic cell differentiation (GO:0097028) | 2.48568323 |
| 138 | mitotic sister chromatid cohesion (GO:0007064) | 2.48264551 |
| 139 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.47641061 |
| 140 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.47641061 |
| 141 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.47641061 |
| 142 | trophectodermal cell differentiation (GO:0001829) | 2.44320311 |
| 143 | negative regulation of gene silencing (GO:0060969) | 2.44247022 |
| 144 | positive regulation of leukocyte degranulation (GO:0043302) | 2.43875251 |
| 145 | response to laminar fluid shear stress (GO:0034616) | 2.43144642 |
| 146 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.42242193 |
| 147 | snRNA metabolic process (GO:0016073) | 2.41730635 |
| 148 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.41728403 |
| 149 | regulation of integrin activation (GO:0033623) | 2.40367747 |
| 150 | protein retention in ER lumen (GO:0006621) | 2.40078345 |
| 151 | positive regulation by symbiont of host defense response (GO:0052509) | 2.39565887 |
| 152 | modulation by symbiont of host defense response (GO:0052031) | 2.39565887 |
| 153 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.39565887 |
| 154 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.39565887 |
| 155 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.39565887 |
| 156 | modulation by symbiont of host immune response (GO:0052553) | 2.39565887 |
| 157 | detection of molecule of bacterial origin (GO:0032490) | 2.39551119 |
| 158 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39528624 |
| 159 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.39478976 |
| 160 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.39452488 |
| 161 | telomere maintenance via telomere lengthening (GO:0010833) | 2.39435159 |
| 162 | positive regulation of antigen processing and presentation (GO:0002579) | 2.38944265 |
| 163 | ribosome assembly (GO:0042255) | 2.38355491 |
| 164 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.38284440 |
| 165 | translational initiation (GO:0006413) | 2.38028656 |
| 166 | cellular response to arsenic-containing substance (GO:0071243) | 2.37841760 |
| 167 | protein localization to chromosome (GO:0034502) | 2.37477484 |
| 168 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.36993358 |
| 169 | regulation of antigen processing and presentation (GO:0002577) | 2.36442078 |
| 170 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.34945862 |
| 171 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.34945862 |
| 172 | negative regulation of RNA splicing (GO:0033119) | 2.34102488 |
| 173 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.33585163 |
| 174 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.33442427 |
| 175 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.32259312 |
| 176 | peptide catabolic process (GO:0043171) | 2.32110521 |
| 177 | regulation of gene silencing (GO:0060968) | 2.31989109 |
| 178 | determination of adult lifespan (GO:0008340) | 2.31707546 |
| 179 | modulation by virus of host process (GO:0019054) | 2.31533506 |
| 180 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.31284024 |
| 181 | adenosine receptor signaling pathway (GO:0001973) | 2.31015711 |
| 182 | mature B cell differentiation involved in immune response (GO:0002313) | 2.30901759 |
| 183 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.30901523 |
| 184 | glucose 6-phosphate metabolic process (GO:0051156) | 2.29822442 |
| 185 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.29808593 |
| 186 | amyloid precursor protein catabolic process (GO:0042987) | 2.29382001 |
| 187 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.28755649 |
| 188 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28535002 |
| 189 | negative regulation of cell size (GO:0045792) | 2.28464410 |
| 190 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.27690336 |
| 191 | positive regulation of cholesterol efflux (GO:0010875) | 2.25903792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.41488894 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.86863447 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.12527595 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.96063255 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89341518 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.85764884 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.50093082 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44748823 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.29264651 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28643319 |
| 11 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.23585133 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.22597275 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21215327 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20211833 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14741130 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.97489651 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89692616 |
| 18 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.84927816 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.79300118 |
| 20 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71564189 |
| 21 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67543601 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56705958 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56680620 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56522568 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56038347 |
| 26 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54685987 |
| 27 | KDM2B_26808549_Chip-Seq_K562_Human | 1.53829152 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.53660633 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52455343 |
| 30 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.52147901 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.51670979 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49726783 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49622816 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49544435 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49361027 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49072817 |
| 37 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.48565679 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47698945 |
| 39 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.45809322 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45628518 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43523244 |
| 42 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42700517 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41698398 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40483653 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.38565546 |
| 46 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37769847 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37741355 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36390793 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36219441 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36125555 |
| 51 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35292614 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34766027 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34533968 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33949048 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33462656 |
| 56 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.33081247 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.33049038 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32590903 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.31218153 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30412691 |
| 61 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29912778 |
| 62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29545853 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28430517 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28270315 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27360718 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27151848 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27096107 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26277297 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.26168478 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25593543 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25525178 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23731113 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23329481 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23027922 |
| 75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.22538755 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22129662 |
| 77 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21616224 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19644736 |
| 79 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.19552852 |
| 80 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.19223258 |
| 81 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19177011 |
| 82 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19060822 |
| 83 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18757079 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18134578 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17731127 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17587408 |
| 87 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.17565873 |
| 88 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.17515134 |
| 89 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17330019 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16744692 |
| 91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16473663 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16002748 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15990009 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15672864 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15503282 |
| 96 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14638680 |
| 97 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.14132592 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13984841 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13202691 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12416044 |
| 101 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.12363660 |
| 102 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10945931 |
| 103 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.09876877 |
| 104 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09497840 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08891335 |
| 106 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08442770 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08435259 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08287848 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07490575 |
| 110 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07378909 |
| 111 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07265829 |
| 112 | * MYB_26560356_Chip-Seq_TH1_Human | 1.07205112 |
| 113 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06889063 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06841356 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05239438 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04920438 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03945642 |
| 118 | MAF_26560356_Chip-Seq_TH2_Human | 1.03812717 |
| 119 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03578375 |
| 120 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02841411 |
| 121 | MYB_26560356_Chip-Seq_TH2_Human | 1.02324929 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02163192 |
| 123 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01818548 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01793673 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01260791 |
| 126 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01133466 |
| 127 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.00721538 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99767616 |
| 129 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.99101431 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98522909 |
| 131 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96615943 |
| 132 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.96127187 |
| 133 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96080279 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95734293 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95286039 |
| 136 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94979634 |
| 137 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94467597 |
| 138 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93845959 |
| 139 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93122260 |
| 140 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92773421 |
| 141 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92751506 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92512697 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92105172 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91319442 |
| 145 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90625075 |
| 146 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90590258 |
| 147 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90283840 |
| 148 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88879386 |
| 149 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85638494 |
| 150 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85283868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.25381451 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.07881106 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 3.02761971 |
| 4 | MP0003111_abnormal_nucleus_morphology | 2.92417818 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 2.78456350 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.66049652 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.62353851 |
| 8 | MP0003077_abnormal_cell_cycle | 2.56804148 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.43132360 |
| 10 | MP0003303_peritoneal_inflammation | 2.42266479 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.32699118 |
| 12 | MP0010307_abnormal_tumor_latency | 2.32187659 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.21128118 |
| 14 | MP0009278_abnormal_bone_marrow | 2.10302312 |
| 15 | MP0001730_embryonic_growth_arrest | 2.03617633 |
| 16 | MP0008057_abnormal_DNA_replication | 1.96271818 |
| 17 | MP0008260_abnormal_autophagy | 1.95518535 |
| 18 | MP0000604_amyloidosis | 1.92067211 |
| 19 | MP0003075_altered_response_to | 1.91769611 |
| 20 | MP0009840_abnormal_foam_cell | 1.89712449 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.81006336 |
| 22 | MP0000350_abnormal_cell_proliferation | 1.78214964 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.77018245 |
| 24 | MP0009785_altered_susceptibility_to | 1.76668249 |
| 25 | MP0002998_abnormal_bone_remodeling | 1.74387395 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.71198879 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 1.71198879 |
| 28 | MP0003436_decreased_susceptibility_to | 1.70754784 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.66927150 |
| 30 | MP0002254_reproductive_system_inflammat | 1.64267423 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.63119727 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.61017550 |
| 33 | MP0000685_abnormal_immune_system | 1.58728086 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.56335488 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.55239141 |
| 36 | MP0003091_abnormal_cell_migration | 1.55159540 |
| 37 | MP0000490_abnormal_crypts_of | 1.51611062 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.51583592 |
| 39 | MP0002398_abnormal_bone_marrow | 1.48540068 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.47932132 |
| 41 | MP0005380_embryogenesis_phenotype | 1.47932132 |
| 42 | MP0001800_abnormal_humoral_immune | 1.47792059 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.45160866 |
| 44 | MP0003329_amyloid_beta_deposits | 1.44864759 |
| 45 | MP0003984_embryonic_growth_retardation | 1.44074021 |
| 46 | MP0004858_abnormal_nervous_system | 1.43091755 |
| 47 | MP0002088_abnormal_embryonic_growth/wei | 1.41650437 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.41108918 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.40496020 |
| 50 | MP0000858_altered_metastatic_potential | 1.39808067 |
| 51 | MP0002086_abnormal_extraembryonic_tissu | 1.39134287 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.37996656 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.37122006 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.36879028 |
| 55 | MP0002405_respiratory_system_inflammati | 1.35713587 |
| 56 | MP0001697_abnormal_embryo_size | 1.35620944 |
| 57 | MP0002722_abnormal_immune_system | 1.33831709 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.33503890 |
| 59 | MP0004197_abnormal_fetal_growth/weight/ | 1.33015977 |
| 60 | MP0005023_abnormal_wound_healing | 1.32119002 |
| 61 | MP0002452_abnormal_antigen_presenting | 1.31941792 |
| 62 | MP0002080_prenatal_lethality | 1.28876570 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.27807833 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.26542888 |
| 65 | MP0004233_abnormal_muscle_weight | 1.24094738 |
| 66 | MP0003724_increased_susceptibility_to | 1.23523655 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.22588960 |
| 68 | MP0000313_abnormal_cell_death | 1.22422738 |
| 69 | MP0001853_heart_inflammation | 1.21226009 |
| 70 | MP0005310_abnormal_salivary_gland | 1.20010905 |
| 71 | MP0001790_abnormal_immune_system | 1.18744007 |
| 72 | MP0005387_immune_system_phenotype | 1.18744007 |
| 73 | MP0009764_decreased_sensitivity_to | 1.18395941 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.17670885 |
| 75 | MP0008469_abnormal_protein_level | 1.17002936 |
| 76 | MP0002420_abnormal_adaptive_immunity | 1.16995353 |
| 77 | MP0002723_abnormal_immune_serum | 1.16288401 |
| 78 | MP0000716_abnormal_immune_system | 1.16184433 |
| 79 | MP0001819_abnormal_immune_cell | 1.15917243 |
| 80 | MP0002429_abnormal_blood_cell | 1.15566335 |
| 81 | MP0003690_abnormal_glial_cell | 1.15562591 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 1.15030541 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.14072167 |
| 84 | MP0008058_abnormal_DNA_repair | 1.14059488 |
| 85 | MP0002084_abnormal_developmental_patter | 1.13458034 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 1.12360460 |
| 87 | MP0003448_altered_tumor_morphology | 1.11955102 |
| 88 | MP0005025_abnormal_response_to | 1.10537441 |
| 89 | MP0002085_abnormal_embryonic_tissue | 1.09569786 |
| 90 | MP0003828_pulmonary_edema | 1.07900946 |
| 91 | MP0008932_abnormal_embryonic_tissue | 1.07733608 |
| 92 | MP0001915_intracranial_hemorrhage | 1.07608210 |
| 93 | MP0003279_aneurysm | 1.05314718 |
| 94 | MP0009672_abnormal_birth_weight | 1.04876008 |
| 95 | MP0000733_abnormal_muscle_development | 1.04114092 |
| 96 | MP0002419_abnormal_innate_immunity | 1.03726931 |
| 97 | MP0004947_skin_inflammation | 1.03408128 |
| 98 | MP0002166_altered_tumor_susceptibility | 1.02154266 |
| 99 | MP0005166_decreased_susceptibility_to | 1.01887913 |
| 100 | MP0003183_abnormal_peptide_metabolism | 1.01264913 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 1.00476992 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98071130 |
| 103 | MP0001849_ear_inflammation | 0.97452752 |
| 104 | MP0008004_abnormal_stomach_pH | 0.96773062 |
| 105 | * MP0000371_diluted_coat_color | 0.93900682 |
| 106 | MP0006082_CNS_inflammation | 0.92541979 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91966630 |
| 108 | MP0002006_tumorigenesis | 0.91154206 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.90159326 |
| 110 | MP0000598_abnormal_liver_morphology | 0.89854282 |
| 111 | MP0000609_abnormal_liver_physiology | 0.87934654 |
| 112 | MP0002796_impaired_skin_barrier | 0.87359690 |
| 113 | MP0003123_paternal_imprinting | 0.86851386 |
| 114 | MP0005409_darkened_coat_color | 0.86815246 |
| 115 | MP0002089_abnormal_postnatal_growth/wei | 0.84577375 |
| 116 | MP0000569_abnormal_digit_pigmentation | 0.84128087 |
| 117 | MP0005165_increased_susceptibility_to | 0.83575472 |
| 118 | * MP0003634_abnormal_glial_cell | 0.83354408 |
| 119 | MP0005390_skeleton_phenotype | 0.83279837 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.83108892 |
| 121 | MP0005621_abnormal_cell_physiology | 0.82935407 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.82695763 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.82180618 |
| 124 | MP0004510_myositis | 0.81918111 |
| 125 | MP0000920_abnormal_myelination | 0.81778886 |
| 126 | MP0005671_abnormal_response_to | 0.78874102 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.78140292 |
| 128 | MP0003795_abnormal_bone_structure | 0.77899469 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.77400250 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.77195258 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.76188375 |
| 132 | MP0000750_abnormal_muscle_regeneration | 0.75087000 |
| 133 | MP0003646_muscle_fatigue | 0.74703823 |
| 134 | MP0009703_decreased_birth_body | 0.73033538 |
| 135 | MP0003186_abnormal_redox_activity | 0.72779548 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.72653649 |
| 137 | MP0008874_decreased_physiological_sensi | 0.71935378 |
| 138 | MP0000343_altered_response_to | 0.71747256 |
| 139 | MP0010630_abnormal_cardiac_muscle | 0.71713429 |
| 140 | MP0009763_increased_sensitivity_to | 0.69712106 |
| 141 | MP0001216_abnormal_epidermal_layer | 0.68069398 |
| 142 | MP0000747_muscle_weakness | 0.67113709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.51766417 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.51766417 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.51766417 |
| 4 | Dysostosis multiplex (HP:0000943) | 4.15114109 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.09459124 |
| 6 | Loss of speech (HP:0002371) | 3.74911156 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.71109983 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.66207385 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.48534111 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29453481 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29453481 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29453481 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.21873270 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.12932702 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.12932702 |
| 16 | Nuclear cataract (HP:0100018) | 3.11976020 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.04336959 |
| 18 | Agnosia (HP:0010524) | 3.02395468 |
| 19 | Axonal loss (HP:0003447) | 2.89329385 |
| 20 | Ependymoma (HP:0002888) | 2.87780166 |
| 21 | Neuronal loss in central nervous system (HP:0002529) | 2.73271976 |
| 22 | Multiple enchondromatosis (HP:0005701) | 2.71953106 |
| 23 | Apathy (HP:0000741) | 2.70476906 |
| 24 | Diminished motivation (HP:0000745) | 2.67692364 |
| 25 | Birth length less than 3rd percentile (HP:0003561) | 2.65911645 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 2.65046674 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.60071751 |
| 28 | Achilles tendon contracture (HP:0001771) | 2.57543339 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.47007981 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46617259 |
| 31 | Pustule (HP:0200039) | 2.45470807 |
| 32 | Purpura (HP:0000979) | 2.44639478 |
| 33 | Basal cell carcinoma (HP:0002671) | 2.42275316 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 2.36053004 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.36053004 |
| 36 | Personality changes (HP:0000751) | 2.35968320 |
| 37 | Abnormality of the fingertips (HP:0001211) | 2.34239241 |
| 38 | Spinal muscular atrophy (HP:0007269) | 2.32438310 |
| 39 | Abnormality of the Achilles tendon (HP:0005109) | 2.32083263 |
| 40 | Recurrent viral infections (HP:0004429) | 2.31952744 |
| 41 | Thoracic kyphosis (HP:0002942) | 2.30807557 |
| 42 | Disinhibition (HP:0000734) | 2.28803142 |
| 43 | Cellulitis (HP:0100658) | 2.28787669 |
| 44 | Recurrent bacterial skin infections (HP:0005406) | 2.28113663 |
| 45 | Selective tooth agenesis (HP:0001592) | 2.27645576 |
| 46 | Distal lower limb amyotrophy (HP:0008944) | 2.27533524 |
| 47 | Increased density of long bones (HP:0006392) | 2.26160548 |
| 48 | Spastic diplegia (HP:0001264) | 2.21701132 |
| 49 | Reticulocytopenia (HP:0001896) | 2.20526974 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.17907183 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.17872234 |
| 52 | Thin bony cortex (HP:0002753) | 2.16945360 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.16885492 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.14721252 |
| 55 | Thrombocytosis (HP:0001894) | 2.14258469 |
| 56 | Upper motor neuron abnormality (HP:0002127) | 2.14133588 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.12615836 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.10497028 |
| 59 | Abnormality of the astrocytes (HP:0100707) | 2.10414215 |
| 60 | Astrocytoma (HP:0009592) | 2.10414215 |
| 61 | Bone pain (HP:0002653) | 2.09197807 |
| 62 | Prominent nose (HP:0000448) | 2.09135087 |
| 63 | IgM deficiency (HP:0002850) | 2.08917392 |
| 64 | High pitched voice (HP:0001620) | 2.08648580 |
| 65 | J-shaped sella turcica (HP:0002680) | 2.07695077 |
| 66 | Hyperacusis (HP:0010780) | 2.07690807 |
| 67 | Ulnar bowing (HP:0003031) | 2.07182627 |
| 68 | Pathologic fracture (HP:0002756) | 2.05747077 |
| 69 | Glomerulonephritis (HP:0000099) | 2.04309988 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03530834 |
| 71 | Mutism (HP:0002300) | 2.03451636 |
| 72 | Prolonged neonatal jaundice (HP:0006579) | 2.03071353 |
| 73 | Obstructive lung disease (HP:0006536) | 2.02979313 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02979313 |
| 75 | Progressive neurologic deterioration (HP:0002344) | 2.02743616 |
| 76 | Abnormal neuron morphology (HP:0012757) | 2.02226030 |
| 77 | Abnormality of the motor neurons (HP:0002450) | 2.02226030 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.00291095 |
| 79 | Metaphyseal cupping (HP:0003021) | 1.99895360 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 1.99743188 |
| 81 | Amyloidosis (HP:0011034) | 1.98416916 |
| 82 | Cervical subluxation (HP:0003308) | 1.98352199 |
| 83 | Cerebral aneurysm (HP:0004944) | 1.96924744 |
| 84 | Rectal prolapse (HP:0002035) | 1.95550799 |
| 85 | Mediastinal lymphadenopathy (HP:0100721) | 1.95520581 |
| 86 | Dementia (HP:0000726) | 1.94654509 |
| 87 | Petechiae (HP:0000967) | 1.94375902 |
| 88 | Broad face (HP:0000283) | 1.93992282 |
| 89 | Abnormality of complement system (HP:0005339) | 1.93129397 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92274321 |
| 91 | Gingivitis (HP:0000230) | 1.90566014 |
| 92 | Protrusio acetabuli (HP:0003179) | 1.89821847 |
| 93 | Genu recurvatum (HP:0002816) | 1.89783127 |
| 94 | Increased serum ferritin (HP:0003281) | 1.89275912 |
| 95 | Absent thumb (HP:0009777) | 1.88009941 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 1.87781673 |
| 97 | Rhabdomyosarcoma (HP:0002859) | 1.87570903 |
| 98 | Angiofibromas (HP:0010615) | 1.87236798 |
| 99 | Adenoma sebaceum (HP:0009720) | 1.87236798 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.87226048 |
| 101 | Ragged-red muscle fibers (HP:0003200) | 1.86948148 |
| 102 | Abnormality of reticulocytes (HP:0004312) | 1.85627775 |
| 103 | Deviation of the thumb (HP:0009603) | 1.85473651 |
| 104 | Trismus (HP:0000211) | 1.85455217 |
| 105 | Myocardial infarction (HP:0001658) | 1.85427505 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 1.85186960 |
| 107 | Colon cancer (HP:0003003) | 1.85006244 |
| 108 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.83779544 |
| 109 | Cortical dysplasia (HP:0002539) | 1.83361648 |
| 110 | Proximal placement of thumb (HP:0009623) | 1.82519996 |
| 111 | Hypertensive crisis (HP:0100735) | 1.82477901 |
| 112 | Amaurosis fugax (HP:0100576) | 1.81190035 |
| 113 | Abnormal platelet function (HP:0011869) | 1.80846739 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.80846739 |
| 115 | Hand muscle atrophy (HP:0009130) | 1.80832823 |
| 116 | Chromsome breakage (HP:0040012) | 1.80098087 |
| 117 | Increased connective tissue (HP:0009025) | 1.79635460 |
| 118 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79163212 |
| 119 | Colitis (HP:0002583) | 1.78326262 |
| 120 | Facial hemangioma (HP:0000329) | 1.78260724 |
| 121 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.77440786 |
| 122 | Cardiomegaly (HP:0001640) | 1.77349511 |
| 123 | Abnormality of lateral ventricle (HP:0030047) | 1.77140923 |
| 124 | Increased IgE level (HP:0003212) | 1.76968882 |
| 125 | Cafe-au-lait spot (HP:0000957) | 1.75447559 |
| 126 | Poikiloderma (HP:0001029) | 1.75210550 |
| 127 | Urethral obstruction (HP:0000796) | 1.74726861 |
| 128 | Hyperparathyroidism (HP:0000843) | 1.74213570 |
| 129 | Malnutrition (HP:0004395) | 1.73874415 |
| 130 | Medulloblastoma (HP:0002885) | 1.73796850 |
| 131 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73009663 |
| 132 | Complement deficiency (HP:0004431) | 1.72521699 |
| 133 | Breast hypoplasia (HP:0003187) | 1.71470613 |
| 134 | Polygenic inheritance (HP:0010982) | 1.70567979 |
| 135 | Esophageal varix (HP:0002040) | 1.69983212 |
| 136 | Myelodysplasia (HP:0002863) | 1.68789781 |
| 137 | Squamous cell carcinoma (HP:0002860) | 1.68781459 |
| 138 | Inflammation of the large intestine (HP:0002037) | 1.68378559 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 1.68201860 |
| 140 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.67668125 |
| 141 | Gastrointestinal carcinoma (HP:0002672) | 1.67668125 |
| 142 | Upper limb amyotrophy (HP:0009129) | 1.66771558 |
| 143 | Distal upper limb amyotrophy (HP:0007149) | 1.66771558 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.66695092 |
| 145 | Restrictive lung disease (HP:0002091) | 1.66373276 |
| 146 | Short humerus (HP:0005792) | 1.66328000 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.66013843 |
| 148 | Reticulocytosis (HP:0001923) | 1.65996975 |
| 149 | Neoplasm of the oral cavity (HP:0100649) | 1.65777615 |
| 150 | Neoplasm of striated muscle (HP:0009728) | 1.65473626 |
| 151 | Pseudobulbar signs (HP:0002200) | 1.65227993 |
| 152 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.64953681 |
| 153 | Cutaneous melanoma (HP:0012056) | 1.64344792 |
| 154 | Hemorrhage of the eye (HP:0011885) | 1.64070113 |
| 155 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.63835478 |
| 156 | Abnormality of the lumbar spine (HP:0100712) | 1.63725133 |
| 157 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.63459860 |
| 158 | Patellar aplasia (HP:0006443) | 1.63403305 |
| 159 | Osteomyelitis (HP:0002754) | 1.63131105 |
| 160 | Spondylolisthesis (HP:0003302) | 1.62429157 |
| 161 | Long eyelashes (HP:0000527) | 1.61845097 |
| 162 | Muscle fibrillation (HP:0010546) | 1.61301554 |
| 163 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.60571404 |
| 164 | Osteolytic defects of the hand bones (HP:0009699) | 1.60571404 |
| 165 | Oral leukoplakia (HP:0002745) | 1.60385366 |
| 166 | Skin tags (HP:0010609) | 1.60204973 |
| 167 | Nasal polyposis (HP:0100582) | 1.59765552 |
| 168 | Leukopenia (HP:0001882) | 1.59376418 |
| 169 | Joint stiffness (HP:0001387) | 1.58379294 |
| 170 | Premature rupture of membranes (HP:0001788) | 1.57554061 |
| 171 | Natal tooth (HP:0000695) | 1.57495110 |
| 172 | Emphysema (HP:0002097) | 1.57196051 |
| 173 | Abnormality of the nasal mucosa (HP:0000433) | 1.56893140 |
| 174 | Bulbar palsy (HP:0001283) | 1.53580639 |
| 175 | Lower limb amyotrophy (HP:0007210) | 1.53246192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.33059450 |
| 2 | TRIB3 | 3.43996214 |
| 3 | CDK12 | 3.36985529 |
| 4 | PKN2 | 3.00054676 |
| 5 | MAP3K10 | 2.96328727 |
| 6 | EEF2K | 2.92670965 |
| 7 | MAP4K1 | 2.83853724 |
| 8 | CDC7 | 2.76105925 |
| 9 | PRPF4B | 2.75437738 |
| 10 | ERN1 | 2.30406765 |
| 11 | SMG1 | 2.25889847 |
| 12 | NEK2 | 2.20390529 |
| 13 | STK10 | 2.15542820 |
| 14 | SCYL2 | 1.97088956 |
| 15 | MAP3K14 | 1.87438244 |
| 16 | WEE1 | 1.75965895 |
| 17 | DDR2 | 1.74032784 |
| 18 | TESK1 | 1.68272495 |
| 19 | MAP3K8 | 1.62982587 |
| 20 | CDC42BPA | 1.60609059 |
| 21 | RPS6KA4 | 1.56043541 |
| 22 | CDK4 | 1.52755761 |
| 23 | TYK2 | 1.52227773 |
| 24 | NME2 | 1.52134927 |
| 25 | MAP2K3 | 1.51896746 |
| 26 | MAP3K13 | 1.51042539 |
| 27 | LRRK2 | 1.50972686 |
| 28 | TTK | 1.48472165 |
| 29 | TTN | 1.46371235 |
| 30 | RPS6KB2 | 1.42000439 |
| 31 | MAP3K11 | 1.41211575 |
| 32 | TAOK1 | 1.37771053 |
| 33 | MOS | 1.37391161 |
| 34 | TGFBR2 | 1.36564885 |
| 35 | GRK7 | 1.33914716 |
| 36 | RIPK4 | 1.33843812 |
| 37 | BUB1 | 1.32300973 |
| 38 | JAK3 | 1.28016948 |
| 39 | ALK | 1.27869885 |
| 40 | MAP3K1 | 1.27518523 |
| 41 | CDK7 | 1.27442326 |
| 42 | ICK | 1.24567015 |
| 43 | NEK1 | 1.23965372 |
| 44 | ZAP70 | 1.22991890 |
| 45 | CDK6 | 1.16662233 |
| 46 | MATK | 1.16428404 |
| 47 | MTOR | 1.15431407 |
| 48 | BLK | 1.14599976 |
| 49 | PTK6 | 1.13122941 |
| 50 | GRK6 | 1.12258225 |
| 51 | FGR | 1.11496178 |
| 52 | IRAK4 | 1.10907282 |
| 53 | TAOK2 | 1.10179337 |
| 54 | ARAF | 1.08366671 |
| 55 | PAK4 | 1.08355482 |
| 56 | PIM1 | 1.07653977 |
| 57 | CAMK1D | 1.03073790 |
| 58 | ATR | 0.98482959 |
| 59 | EPHA2 | 0.97588661 |
| 60 | BMX | 0.97183336 |
| 61 | EPHB1 | 0.94925422 |
| 62 | PLK1 | 0.92487616 |
| 63 | IRAK2 | 0.92468962 |
| 64 | ABL2 | 0.91481873 |
| 65 | MARK2 | 0.90011269 |
| 66 | TBK1 | 0.89989150 |
| 67 | RPS6KA2 | 0.89180020 |
| 68 | EIF2AK1 | 0.87486814 |
| 69 | CHEK1 | 0.84008554 |
| 70 | FLT3 | 0.83657238 |
| 71 | CSF1R | 0.83371006 |
| 72 | CHEK2 | 0.82874158 |
| 73 | PDPK1 | 0.82672889 |
| 74 | PRKD2 | 0.82662845 |
| 75 | BRD4 | 0.82323352 |
| 76 | AURKB | 0.82052749 |
| 77 | MST1R | 0.81828907 |
| 78 | STK3 | 0.78572403 |
| 79 | MAP3K3 | 0.76790854 |
| 80 | BTK | 0.76758850 |
| 81 | TSSK6 | 0.76233847 |
| 82 | LATS2 | 0.72869978 |
| 83 | STK4 | 0.71483703 |
| 84 | PIM2 | 0.70347426 |
| 85 | MAP3K6 | 0.69210059 |
| 86 | MAP3K5 | 0.68489850 |
| 87 | RPS6KL1 | 0.67997032 |
| 88 | RPS6KC1 | 0.67997032 |
| 89 | LIMK1 | 0.67841116 |
| 90 | CSK | 0.67605398 |
| 91 | KSR2 | 0.67159979 |
| 92 | SIK1 | 0.67151004 |
| 93 | PTK2 | 0.66943440 |
| 94 | CDK2 | 0.66883002 |
| 95 | HCK | 0.65603230 |
| 96 | DYRK3 | 0.65017711 |
| 97 | TESK2 | 0.64584327 |
| 98 | LATS1 | 0.64461619 |
| 99 | SIK2 | 0.64303318 |
| 100 | RIPK1 | 0.64006576 |
| 101 | CHUK | 0.63507848 |
| 102 | PDGFRA | 0.62759042 |
| 103 | KDR | 0.61938917 |
| 104 | TYRO3 | 0.60470329 |
| 105 | SIK3 | 0.59631245 |
| 106 | ATM | 0.59582726 |
| 107 | FGFR4 | 0.55707303 |
| 108 | JAK2 | 0.55248497 |
| 109 | MAPKAPK3 | 0.54386625 |
| 110 | PASK | 0.54252166 |
| 111 | KIT | 0.54106422 |
| 112 | SYK | 0.53044337 |
| 113 | LMTK2 | 0.52641761 |
| 114 | HIPK2 | 0.52092108 |
| 115 | PAK2 | 0.51587000 |
| 116 | AURKA | 0.51468600 |
| 117 | ACVR1B | 0.50689038 |
| 118 | MELK | 0.50332487 |
| 119 | TGFBR1 | 0.50137105 |
| 120 | MAP3K9 | 0.50127816 |
| 121 | PRKG2 | 0.49584786 |
| 122 | IKBKE | 0.48318996 |
| 123 | PAK1 | 0.48255731 |
| 124 | LCK | 0.47866282 |
| 125 | CDK9 | 0.47697711 |
| 126 | PDK1 | 0.47610132 |
| 127 | IKBKB | 0.47608920 |
| 128 | DMPK | 0.47439016 |
| 129 | CAMK1G | 0.47271896 |
| 130 | JAK1 | 0.46719752 |
| 131 | BRSK2 | 0.44182547 |
| 132 | RPS6KA6 | 0.44154852 |
| 133 | MARK3 | 0.43929589 |
| 134 | BRAF | 0.43752722 |
| 135 | RPS6KA1 | 0.42967483 |
| 136 | FES | 0.42196696 |
| 137 | AKT2 | 0.40780666 |
| 138 | MAPK11 | 0.40441250 |
| 139 | EGFR | 0.40335264 |
| 140 | CLK1 | 0.40043703 |
| 141 | PRKD3 | 0.38943110 |
| 142 | MAPKAPK2 | 0.38817251 |
| 143 | DAPK3 | 0.36434416 |
| 144 | LYN | 0.36416744 |
| 145 | NEK9 | 0.34569828 |
| 146 | MAP2K2 | 0.33054276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.19079118 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.59415173 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.94731485 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.72496413 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.43170745 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.41387294 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.38113895 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.13060002 |
| 9 | Cell cycle_Homo sapiens_hsa04110 | 2.02647762 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 1.95447039 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.78761642 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.77480789 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.65153303 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54589114 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 1.51389338 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.51095586 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.49434358 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.48319265 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48253568 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.48161746 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47087599 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46019866 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.45019656 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42751976 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.41503835 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.38484089 |
| 27 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.37566151 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.35343027 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30126870 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30098622 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29629950 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28270509 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.27244877 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26581507 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24562200 |
| 36 | Ribosome_Homo sapiens_hsa03010 | 1.23513323 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.21707657 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21057413 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19895804 |
| 40 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 1.19011536 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.18674405 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18201992 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17751450 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16603851 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16075130 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.15001354 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.14891983 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13292189 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12772982 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10906203 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10386042 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08719717 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08598621 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.05899119 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05690918 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05139315 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05109234 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04903431 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04174579 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 1.01471826 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.01174681 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 1.00183365 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00017544 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98670381 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98344553 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.96010358 |
| 67 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.95842833 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92208607 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.91835917 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91320883 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.89693132 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86629746 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84579181 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.84501528 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83594878 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83449078 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83200760 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82398434 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82143808 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81812771 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81391909 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81211755 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79821789 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75410462 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75285861 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74394247 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72728841 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72519118 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71843149 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71722300 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70914600 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70428186 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.69739148 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69142958 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68919007 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.66983497 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66809161 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66720401 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66555600 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66397171 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.66004662 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65966200 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.65678826 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.64612205 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64599716 |
| 106 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64414653 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62442912 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62131580 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.62030958 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61873449 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61002083 |
| 112 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60400058 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58533776 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57991704 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57443637 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56201853 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55826163 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55389508 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55310325 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54896616 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54640441 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54559685 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54513817 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53962253 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52546563 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52215393 |
| 127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52015946 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50366656 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49995467 |
| 130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49143605 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47747181 |
| 132 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46967016 |
| 133 | Proteasome_Homo sapiens_hsa03050 | 0.46282776 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46275316 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46088874 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45777050 |
| 137 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45528080 |
| 138 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44978006 |
| 139 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43788088 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43766991 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43347533 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.42455358 |
| 143 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42166764 |
| 144 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40623197 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.39721432 |

